Skip to main content
Fig. 3 | World Journal of Surgical Oncology

Fig. 3

From: Prognostic significance and survival benefits of postoperative adjuvant chemotherapy in patients with stage IA lung adenocarcinoma with non-predominant micropapillary components

Fig. 3

Kaplan–Meier survival curves for patients with a micropapillary component > 5%. A Recurrence-free survival before PSM; B Recurrence-free survival after PSM; C Overall survival before PSM; D Overall survival after PSM; E Disease-specific survival before PSM; F Disease-specific survival after PSM. PSM, propensity score matching

Back to article page